Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

NF-1, Nutraceutical Intervention

Study ID: NCT05363267
Start Date: 2022-07-06
End Date: 2026-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

curcumin, high phenolic extra virgin olive oil (HP-EVOO)

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Study ID: NCT03879694
Start Date: 2019-06-17
End Date: 2026-12-17
Study Type

Interventional

Study Phase

Phase1

No. of Participants

14

Intervention / Treatment

Incomplete Freund's Adjuvant

Octreotide Acetate

Sargramostim

SVN53-67/M57-KLH Peptide Vaccine

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Study ID: NCT05886491
Start Date: 2023-07-11
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

53

Intervention / Treatment

GDX012

Chemotherapy Agents

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia

Study ID: NCT05520567
Start Date: 2023-01-31
End Date: 2028-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

Gillter

Venetoclax

Azacitidine

Sponsor

Astellas Pharma Global Development, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Study ID: NCT05286801
Start Date: 2022-11-17
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

86

Intervention / Treatment

Atezolizumab

Biospecimen Collection

Computed Tomography

Echocardiography Test

Fludeoxyglucose F-18

Magnetic Resonance Imaging

Positron Emission Tomography

Tiragolumab

X-Ray Imaging

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM)

Study ID: NCT06055894
Start Date: 2023-09-20
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Omega-3

Curcumin

Probiotic

Whole food, plant-based diet (WFPBD)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

Study ID: NCT04324294
Start Date: 2020-02-26
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

200

Intervention / Treatment

EUS enhanced with contrast to evaluate pancreas

Sponsor

Cedars-Sinai Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Lung Cancer Screening in High-risk Black Women

Study ID: NCT05898594
Start Date: 2023-09-06
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

900

Intervention / Treatment

Low-dose Computed Tomography

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Study ID: NCT06750094
Start Date: 2024-12-12
End Date: 2029-04-13
Study Type

Interventional

Study Phase

Phase3

No. of Participants

700

Intervention / Treatment

Amivantamab

Cetuximab

Infatuating

5-fluorouracil

Leucovorin calcium/levoleucorin

Irinotecan

Sponsor

Janssen Research & Development, LLC

Source: clinicaltrials.gov

Share:
Add to list

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Study ID: NCT06952660
Start Date: 2025-05-07
End Date: 2028-12-13
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Tivdak

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list